Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
#3502 Lifestyle and neuroendocrine tumor (NET) development
Introduction: There has been increasing interest in the relationship between lifestyle and NET. However, no review focusing solely on lifestyle as a risk factor for NET has previously been performed.
Conference:
Presenting Author: Bogaards M
Authors: Bogaards M, May A, Hassan F, Valk G, van Leeuwaarde R,
Keywords: neuroendocrine tumor, smoking, alcohol, diet, physical activity, body mass index, lifestyle,
Introduction: Next generation sequencing based somatic tumor mutation as well as germline mutation data is being increasingly used in cancer management. Pan tumor type FDA approval for NTRK fusion, intermediated-high tumor mutation burden and MSI high status has paved way for tissue agnostic molecularly targeted therapies. Utilization of NGS in neuroendocrine tumor (NET) and neuroendocrine carcinoma (NEC) is currently unknown.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author:
Authors: Chauhan A, Munir A, Hernando J, Leeuwaarde R, Zhang P,
#3186 Bronchopulmonary neuroendocrine tumors (bpNET) - A comparison of three subgroups
Introduction: bpNET are a rare malignancy of the lung, that arise sporadically (sp-bpNET), in the context of Multiple Endocrine Neoplasia Type 1 (MEN1) syndrome, or in the context of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH). Until now, bpNET of any type are regarded as similar entities. Clinically however, bpNET within MEN1 or DIPNECH rarely metastasize or lead to bpNET related death.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author: Levy S
Authors: Levy S, van den Broek M, Dijke K, Hartemink K, van Leeuwaarde R,
#2122 Is the EORTC QLQ-QNET21 Optimal for Patients with Neuroendocrine Tumors?
Introduction: Quality of life (QoL) is important to all cancer patients. The EORTC QLQ-QNET21 is the most commonly used questionnaire in patients with neuroendocrine tumors (NETs).
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: van Leeuwaarde R
Authors: Van Leeuwaarde R, Spada F, Cheung W, Gonzalez-Clavijo A, Pracht M,
Keywords: Quality of life, GEP-NET, EORTC QLQ-GINET21,
Introduction: Multiple Endocrine neoplasia type 1 (MEN1) is a hereditary tumor syndrome, characterized by an increased lifetime risk of benign and malignant endocrine tumors in various organs. Data on quality of life (QoL) in patients with MEN1 are scarce, whereas QoL is considered an important treatment outcome.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Van Leeuwaarde R
Authors: Van Leeuwaarde R, Beijers H, de Herder W, Dekkers O, Van der Horst-Schrivers A,